Back | Next |
home / stock / mmirf / mmirf message board
Subject | By | Source | When |
---|---|---|---|
$mmirf $0.19139 ^ 0.01491 (8.45%) | Taurus69 | investorshub | 11/19/2020 9:16:32 PM |
$mmirf $0.177 v -0.021 (-10.61%) | Taurus69 | investorshub | 11/10/2020 4:28:32 AM |
$mmirf $.50 with news | Taurus69 | investorshub | 11/01/2020 2:36:08 AM |
$mmirf $0.212863 v -0.003137 (-1.45%) | Taurus69 | investorshub | 10/30/2020 10:11:48 PM |
Oh what a SCAM! | shajandr | investorshub | 10/30/2020 5:54:54 PM |
$mmirf $0.22093 v -0.00907 (-3.94%) | Taurus69 | investorshub | 10/22/2020 9:34:18 PM |
Need that FDA stamp of approval... so quite | Steve1978 | investorshub | 10/11/2020 3:00:20 AM |
NEWS!!! LETS GO!!! :))))))) | Chrism0000 | investorshub | 10/07/2020 4:32:37 PM |
NEWS!!! LETS GO!!! :))))))) | Chrism0000 | investorshub | 10/07/2020 4:32:36 PM |
Quick Covid-19 Test are back in the forefront | Steve1978 | investorshub | 10/05/2020 6:57:27 PM |
$mmirf $0.2076 v -0.000462 (-0.22%) | Taurus69 | investorshub | 10/03/2020 5:42:02 PM |
$mmirf $0.2164 v -0.00391 (-1.77%) | Taurus69 | investorshub | 09/30/2020 1:12:38 AM |
Surprised FDA approval is still pending... any second now | Steve1978 | investorshub | 09/22/2020 4:47:47 PM |
Copied from another board We had such an incredible | Steve1978 | investorshub | 09/18/2020 12:47:17 PM |
Should be a green day today | Paraceratherium | investorshub | 09/18/2020 10:09:18 AM |
Just a few short months ago, 6 months | Paraceratherium | investorshub | 09/18/2020 10:08:48 AM |
Need the FDA approval... anytime now | Steve1978 | investorshub | 09/11/2020 2:24:00 AM |
FDA Approval ANYDAY!!! Best Test on the Market!! ! | Steve1978 | investorshub | 09/10/2020 2:47:37 AM |
stock looking good today | Paraceratherium | investorshub | 09/08/2020 2:32:43 PM |
New German report puts a target price of | Paraceratherium | investorshub | 09/06/2020 7:58:29 AM |
News, Short Squeeze, Breakout and More Instantly...
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2024. Corporate update In Q3 FY2024, MedMira focused on the launch of MedMira's latest US FDA approved Reveal ® G4 Rapid HIV 1/2 antibody...
HALIFAX, NS / ACCESSWIRE / April 30, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development. Ms. Bell brings over 20 years of Business Development a...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...